Introduction {#Sec1}
============

Reductive whole-cell biotransformation is an important method for stereoselective industrial synthesis of chemical compounds. A variety of dehydrogenases catalyzes the enantio- and regioselective reduction of ketones and depends on nicotinamide adenine dinucleotide coenzymes (NADH or NADPH) for hydride transfer. Especially alcohol dehydrogenases are most interesting for the production of chiral alcohols because these enzymes show notable chemo-, regio-, and enantioselectivity (Goldberg et al. [@CR11]). Efficient coenzyme recycling by recombinant enzymes converting the oxidized coenzyme back to its reduced form is essential for the productivity of reductive whole-cell biotransformations. In *Escherichia coli*, diverse strategies for cofactor regeneration have been applied: one-enzyme-coupled systems (Eguchi et al. [@CR7]; Ernst et al. [@CR8]; Seelbach et al. [@CR28]; Wichmann and Vasic-Racki [@CR34]) and approaches taking advantage of the metabolism of the cell (Walton and Stewart [@CR32]; Chin et al. [@CR5]; Fasan et al. [@CR9]; Blank et al. [@CR2], [@CR3]).

In a recent study with *E. coli*, we analyzed the NADPH-dependent reduction of the prochiral β-ketoester methyl acetoacetate (MAA) to the chiral hydroxy ester (*R*)-methyl 3-hydroxybutyrate (MHB) using glucose as substrate for the generation of NADPH (Siedler et al. [@CR29]). The reduction is catalyzed by an *R*-specific alcohol dehydrogenase (ADH) from *Lactobacillus brevis*, and MHB serves as a building block of statins (Panke and Wubbolts [@CR19]). Redirection of glucose catabolism from glycolysis to the pentose phosphate pathway (PPP) was accomplished by deletion of phosphoglucose isomerase (*pgi*) or the phosphofructokinase isoenzyme (*pfkA*, *pfkB*) genes resulting in a higher MHB to glucose yield (Siedler et al. [@CR29]). Similar results were obtained in a parallel study analyzing the reduction of xylose to xylitol in *E. coli* with an NADPH-dependent xylose reductase from *Candida boidinii* (Chin and Cirino [@CR4]). Based on the product/glucose yields obtained with the Δ*pfkA*Δ*pfkB* mutant, a partial cyclization of the PPP was assumed because these yields were near the theoretical maximum yield of 6 mol reduced product per mole of glucose consumed (Kruger and von Schaewen [@CR16]).

To further elucidate and verify this assumption, we performed ^13^C-based metabolic flux analyses with the Δ*pfkA* mutant in comparison to the Δ*pgi* mutant, where a linear flux through the PPP is anticipated, as well as with the reference strain *E. coli* BL21(DE3). ^13^C-based metabolic flux analysis is a key technology for attaining an overview on the carbon fluxes within the cell. It also represents the only technique to date that allows the determination of the cofactor regeneration rate, which is a valuable parameter for estimating for the capacity of metabolism for redox biocatalysis (Blank et al. [@CR2]).

Furthermore, we tested the influence of an alternative glucose uptake system on the performance of the reductive biotransformation. For this purpose, we introduced into the *E. coli* strains the *glf* and *glk* genes of *Zymomonas mobilis* ATCC29191, which encode the glucose facilitator (Glf) and glucokinase (Glk). *Z. mobilis* has a three to ten times higher glucose uptake rate than *E. coli*, which is due to the high velocity of the glucose facilitator Glf (Parker et al. [@CR20]; Weisser et al. [@CR33]). Overexpression of *glf* is feasible for increasing the glucose uptake rate of *E. coli* and was successfully used in combination with the cofactor regenerating system glucose dehydrogenase for production of α-pinene oxide (Schewe et al. [@CR25]) and mannitol (Kaup et al. [@CR14], [@CR15]).

Materials and methods {#Sec2}
=====================

Bacterial strains and plasmids {#Sec3}
------------------------------

Strains and plasmids used in this work are listed in Table [1](#Tab1){ref-type="table"}. The mutant strains were constructed as described previously (Siedler et al. [@CR29]). *E coli* strains were transformed by the method described by Hanahan ([@CR12]). Plasmids were selected by adding antibiotics to the medium at final concentrations of 100 μg ampicillin per milliliter (pBtac-*Lbadh*) and 50 μg kanamycin (pVWEx1, pVWEx1-*glf-glk*).Table 1Strains and plasmids used in this workStrains and plasmidsRelevant characteristicsReferenceStrains BL21 Star (DE3) (reference)F^--^*omp*T *hsdS*~B~(r~B~^--^, m~B~^--^) *gal dcm rne*131 (DE3)Invitrogen Δ*pgi*BL21 Star (DE3) Δ*pgi*(Siedler et al. [@CR29]) Δ*pfkA*BL21 Star (DE3) Δ*pfkA*(Siedler et al. [@CR29]) Δ*pfkA*Δ*pfkB*BL21 Star (DE3) Δ*pgi*(Siedler et al. [@CR29]) SS01BL21 Star (DE3) with pBtac-*Lbadh*(Siedler et al. [@CR29]) SS02BL21 Star (DE3) Δ*pgi* with pBtac-*Lbadh*(Siedler et al. [@CR29]) SS03BL21 Star (DE3) Δ*pfkA* with pBtac-*Lbadh*(Siedler et al. [@CR29]) SS04BL21 Star (DE3) Δ*pfkA*Δ*pfkB* with pBtac-*Lbadh*(Siedler et al. [@CR29])Plasmids pBTac1Amp^R^, P~tac~, *lacI*; expression vector for *E. coli*Boehringer Mannheim GmbH pBTac-*Lbadh*pBtac1 derivative with *adh* gene from *Lactobacillus brevis*X-Zyme, (Ernst et al. [@CR8]) pVWEx1Kan^R^; *C. glutamicum*/*E. coli* shuttle vector (*P*~*tac*~, *lacI*^q^; pHM1519, *oriV*~*C.\ glutamicum*~, *oriV*~*E.\ coli*~)(Peters-Wendisch et al. [@CR21]) pVWEx1-*glf-glk*pVWEx1 derivative with *glf* and *glk* genes from *Zymomonas mobils*Eggeling et al. unpublished

Media and growth conditions {#Sec4}
---------------------------

Cells were cultivated in LB medium, 2xYT medium (16 g L^−1^ tryptone, 10 g L^−1^ yeast extract, 5 g L^−1^ sodium chloride) or M9 minimal medium (Sambrook and Russell [@CR23]) containing 4 g L^−1^ glucose and supplemented with 1 mg mL^−1^ thiamine, 4 mg L^−1^ FeSO~4~ × 7 H~2~O, 1 mg L^−1^ MnSO~4~, 0.2 mg L^−1^ ZnSO~4~ × 7 H~2~O, 0.4 mg L^−1^ CoCl~2~, 0.1 mg L^−1^ CuCl~2~, 0.2 mg L^−1^ Na~2~MoO~4~ × 2 H~2~O, and 0.005 mg L^−1^ H~3~BO~3~. Solid media contained 1.5% (*w*/*v*) agar. Liquid cultures were routinely incubated in test tubes or 500-mL-baffled Erlenmeyer flasks overnight at 37 °C and 130 rpm. For stock cultures, 1 mL of overnight LB culture was gently mixed with 1 mL 30% (*v*/*v*) glycerol and stored at −80 °C.

^13^C-Labeling experiments {#Sec5}
--------------------------

The first preculture of *E. coli* was performed in 5 mL of LB medium for 9 h at 37 °C and 130 rpm. The cells were then transferred to the second preculture containing 10 mL of M9 minimal medium and grown overnight at 37 °C and 130 rpm, followed by inoculation of 50 mL of M9 medium after a washing step with M9 medium without glucose to an OD~600~ of 0.05. In the main culture (50 mL M9 medium in a 500-mL Erlenmeyer flask) a mixture of 80% naturally labeled glucose and 20% \[U-^13^C\] glucose was used. Samples were taken to determine the growth rate and the glucose uptake rate. For ^13^C, metabolic flux analysis cells from 2-mL cultures were harvested during the exponential growth phase at an OD~600~ of \~0.7.

The cells were washed with cold 2.7% (*w*/*v*) NaCl solution; the pellets were resuspended in 6 M HCl and incubated for 24 h at 105 °C for hydrolysis of proteins. The samples were dried in a Speedvac (Eppendorf concentrator 5301) under a hood. The dried hydrolysates were derivatized for Gas chromatography and mass spectrometry (GC--MS) analysis using 50 μL *N*,*N*-dimethylformamide and 50 μL *N*-(tert-butyldimethylsilyl)-*N*-methyltrifluoroacetamide. GC--MS analysis was carried out using a GC 3800, combined with an MS/MS 1200 unit (Varian Deutschland GmbH, Darmstadt, Germany). Fifteen detectable amino acids were separated on a FactorFour VF-5ms column (Varian Deutschland GmbH) at a constant flow rate of 1 mL helium per minute. The split ratio was 1:20, the injection volume was 1 μL, and the injector temperature was 250 °C. The temperature of the GC oven was kept constant for 2 min at 150 °C and was afterwards increased to 250 °C with a slope of 3 °C min^−1^. The temperature of the transfer line and the source was 280 and 250 °C, respectively. Ionization was performed by electron impact ionization at −70 eV. For enhanced detection, a selected ion monitoring frame was defined for every amino acid (Wittmann [@CR35]) GC--MS raw data were analyzed using the Workstation MS Data Review (Varian Deutschland GmbH) to check for detector overload (Heyland et al. [@CR13]).

^13^C-constrained metabolic flux analysis {#Sec6}
-----------------------------------------

The stoichiometric model, implemented in FiatFlux (Zamboni et al. [@CR38]) for ^13^C-constrained metabolic flux analysis comprises the major pathways of *E. coli* central carbon metabolism (Fischer et al. [@CR10]). To calculate intracellular fluxes, the stoichiometric model was constrained with three extracellular fluxes (growth rate, glucose uptake rate, and acetate formation rate) and five intracellular flux ratios (fraction of oxaloacetate originating from phosphoenolpyruvate, fraction of oxaloacetate derived through anaplerosis, fraction of phosphoenolpyruvate originating from oxaloacetate, and upper and lower bounds of pyruvate derived through malic enzyme). Error minimization during flux calculation using the determined equation system was carried out as described previously (Fischer et al. [@CR10]). The method for the determination of flux ratios is described in detail by Nanchen and coworkers (Nanchen et al. [@CR18]), while the ^13^C-constrained flux analysis is described by Zamboni and coworkers (Zamboni et al. [@CR39]).

Whole-cell biotransformation {#Sec7}
----------------------------

For cultivation of the different recombinant *E. coli*, BL21(DE3) strains carrying the plasmids pBtac-*Lbadh* and pVWEx1 or pVWEx1-*glf-glk*, a single colony of each strain, was inoculated into 5 mL of 2xYT medium containing the appropriate antibiotics and grown overnight at 37 °C and 170 rpm. These pre-cultures were used for inoculation of the main cultures to an OD~600~ of 0.05. Main cultures were grown in 100 mL of 2xYT medium in the presence of the appropriate antibiotics at 37 °C and 130 rpm to an OD~600~ of 0.3, induced with 1 mM of IPTG, incubated at 37 °C and 130 rpm for another 3 h and harvested at an OD~600~ between 2 and 4.5, which had been determined as the optimal cell density for subsequent whole-cell biotransformation.

The cells were harvested by centrifugation (4,000×*g*, 7 min) and resuspended in reaction buffer containing 278 mM glucose, 2 mM MgSO~4~, and 250 mM potassium phosphate buffer, pH 6.5, to a cell density of 3 g cell dry weight (cdw) per liter. The reaction started by adding 60 mM of MAA. Biotransformations were performed at 37 °C and 130 rpm to prevent cell sedimentation. Specific productivities (millimole MHB per hour per gram cdw) were determined by taking samples at 15-min time intervals over a period of 2 h. MHB and glucose concentrations of the samples were determined (see below). Specific productivities were calculated by dividing the slope of graphs showing MHB concentration vs. time by the cell dry weight.

Analysis of substrates and products {#Sec8}
-----------------------------------

Methyl acetoacetate (MAA), (*R*)-methyl 3-hydroxybutyrate (MHB), glucose and extracellular metabolites were analyzed by HPLC as described previously (Siedler et al. [@CR29]). Glucose concentrations were also determined enzymatically by using the glucose Gluc-DH FS\* Kit according to the instructions of the manufacturer (DiaSys, Holzheim, Germany).

Results {#Sec9}
=======

Growth behavior of reference and mutant strains {#Sec10}
-----------------------------------------------

The growth kinetics of the reference and deletion strains were determined in M9 minimal medium (Fig. [1](#Fig1){ref-type="fig"}). The reference strain *E. coli* BL21(DE3) had the highest growth rate of 0.60 h^−1^ followed by the Δ*pfkA* mutant and the Δ*pgi* mutant with 0.18 and 0.11 h^−1^, respectively (Table [2](#Tab2){ref-type="table"}). The specific glucose uptake rate was very high for the reference strain (11.3 mmol h^−1^ g~cdw~^−1^) but in the range of previously reported values (Toya et al. [@CR31]) and significantly lower for the Δ*pfkA* mutant (4.0 mmol h^−1^ g~cdw~^−1^) and the Δ*pgi* mutant (2.7 mmol h^−1^ g~cdw~^−1^). We chose the Δ*pfkA* mutant instead of the Δ*pfkA*Δ*pfkB* mutant for flux analysis because of the very slow growth of the latter strain in glucose minimal media (Table [2](#Tab2){ref-type="table"}).Fig. 1**a** Growth of *E. coli* BL21(DE3) (*black triangle*) and the mutants Δ*pfkA* (*white triangle*) and Δ*pgi* (*gray triangle*). **b** Glucose uptake of *E. coli* BL21(DE3) (*black square*) and the mutants Δ*pfkA* (*white square*) and Δ*pgi* (*gray square*)Table 2Growth rates, glucose uptake rates, and cell yields (gram cdw per gram glucose) of the reference strain *E. coli* BL21(DE3) and three deletion mutants used in this studyStrainGrowth rate μ (h^−1^)Glucose uptake rate (mmol h^−1^ g~cdw~^−1^)Cell yield Y~X/S~ (g g^−1^)Reference0.60 ± 0.0111.33 ± 0.020.36 ± 0.01Δ*pgi*0.11 ± 0.012.76 ± 0.090.28 ± 0.01Δ*pfkA*0.18 ± 0.014.00 ± 0.080.28 ± 0.01Δ*pfkA*Δ*pfkB*0.01 ± 0.01ndndMean values and standard deviations from at least three independent experiments are shown*nd* not determined

In order to show cyclization of the PPP and to gain more insight into the metabolic network upon genetic perturbation of glycolysis, we measured the carbon fluxes of the reference strain and of the deletion strains Δ*pgi* and Δ*pfkA* during growth in minimal medium with glucose as the sole carbon source (Fig. [2](#Fig2){ref-type="fig"}). Samples were taken in the early exponential growth phase at an OD~600~ of \~0.7 where pseudo steady state conditions can be assumed. The reference strain showed similar flux distributions as reported previously for a batch culture with exception of a higher flux through the tricarboxylic acid (TCA) cycle and a much lower acetate formation (Toya et al. [@CR31]). These differences might be due to the different origins of the *E. coli* B strain BL21(DE3) and the *E. coli* K12 strain BW25113 used by Toya and coworkers. The Δ*pgi* mutant of BL21(DE3) showed a linear flux through the PPP, similar to the BW25113-derived Δ*pgi* mutant, but again a twofold higher flux through the TCA cycle. The Δ*pfkA* mutant of BL21(DE3) showed a partial cyclization of the PPP with a negative net flux through the reaction from glucose 6-phosphate to fructose 6-phosphate catalyzed by phosphoglucose isomerase. This was consistent with the estimated carbon flux-based on the molar product per glucose yield achieved in the biotransformations reported previously (Chin and Cirino [@CR4]). According to our flux analysis, the Δ*pfkA* mutant possessed about 30% residual phosphofructokinase activity. This value is close to the one obtained by in vitro enzyme activity measurements with cell extracts, which revealed 20% residual phosphofructokinase activity in this mutant (Siedler et al. [@CR29]). The residual activity is due to the PfkII isoenzyme.Fig. 2Results of ^13^C-based metabolic flux analysis of *E. coli* BL21(DE3) (*upper number*) and mutant strains Δ*pgi* (*middle number*) and Δ*pfkA* (*lower number*) during exponential growth on glucose. In vivo carbon fluxes in central metabolism are shown as millimole per hour per gram cdw. Relative to the glucose uptake rate, the confidence intervals were 20% for the NADPH balance, below 15% for TCA cycle and malic enzyme, and less than 5% for all other fluxes. *Arrowheads* indicate the direction of a given flux

Additionally, we calculated the NADH regeneration rates and the fluxes through the soluble transhydrogenase for an estimation of the reduced cofactor availability in the cells (Table [3](#Tab3){ref-type="table"}). The NADH regeneration rates relative to the glucose uptake rates of all strains were similar, in contrast to a significantly higher flux through the soluble transhydrogenase UdhA in the Δ*pfkA* mutant (Table [3](#Tab3){ref-type="table"}).Table 3NADH regeneration rates and fluxes through transhydrogenase UdhA calculated from the ^13^C metabolic flux analysisGlucose uptake rateNADH regeneration rateNADPH + NAD^+^ → NADP^+^ + NADH(mmol g~cdw~^-1^ h^−1^)Percent(mmol g~cdw~^−1^ h^−1^)Percent(mmol g~cdw~^−1^ h^−1^)PercentReference strain11.310021.118610.593Δ*pgi*2.81005.82056.4229Δ*pfkA*41008.120315.1378The glucose uptake rates were set to 100%

Improvement of glucose uptake in whole-cell biotransformations {#Sec11}
--------------------------------------------------------------

The ^13^C metabolic flux analysis had indicated a very low flux through the reaction catalyzed by pyruvate kinase in the Δ*pgi* and especially the Δ*pfkA* mutant (Fig. [2](#Fig2){ref-type="fig"}), indicating that glucose uptake could be limited by PEP availability. This was also supported by the much lower specific glucose uptake rates of these two mutants (Table [2](#Tab2){ref-type="table"}). Therefore, we tried to increase the glucose uptake rate and possibly also the biotransformation rate by introduction of an additional glucose uptake system. The glucose facilitator Glf from *Z. mobilis*, a transporter with a high velocity but a low affinity (Parker et al. [@CR20]; Weisser et al. [@CR33]), and the glucose kinase Glk of the same organism was chosen as an alternative pathway for increasing the rate of glucose uptake. As in our previous studies, the NADPH-dependent reduction of MAA to MHB by the (*R*)-specific alcohol dehydrogenase of *Lactobacillus brevis* was used as a model reaction for biotransformation, and the corresponding *adh* gene was overexpressed in all strains.

Overexpression of *glf* and *glk* using plasmid pVWEx1*-glf-glk* in the reference strain SS01 (*E. coli* BL21(DE3) containing pBTac-*Lbadh*) led to a 46% increased specific glucose uptake rate (Table [4](#Tab4){ref-type="table"}), confirming the functional expression of the heterologous genes. However, the higher glucose uptake rate did not result in a higher biotransformation rate compared to the control strain SSO1 with plasmid pVWEx1. The molar yield of MHB per glucose was even decreased by 34% in strain SS01/pVWEx1-*glf-glk* (Table [4](#Tab4){ref-type="table"}). Expression of *glf* and *glk* in strains SS02 (containing the *pgi* deletion) and SS03 (containing the *pfkA* deletion) led to 30% and 41% increased glucose uptake rates, respectively, and also to 15% and 20% improved MHB production rates, compared to the corresponding strains with the empty vector pVWEx1. The ratio of MHB produced per glucose consumed decreased also in these strains by 11% (Δ*pgi* mutant) and 6% (Δ*pfkA* mutant) compared to the corresponding reference strains. This decrease could be due to the overexpression of *glf* and *glk*, leading to a high metabolic burden of heterologous protein production (Schweder et al. [@CR27]; Dong et al. [@CR6]; Bhattacharya and Dubey [@CR1]). In the case of strain SS04 (deletion of *pfkA* and *pfkB*), overexpression of *glf* and *glk* led to a 40% increased glucose uptake rate, whereas the MHB production rate was slightly decreased by 4% and the molar yield by 31% compared to the reference strain. The presence of the vector pVWEx1 showed no significant influence in strains SS01, SS02, and SS03 compared to the strains without this plasmid, but caused a much lower specific MHB production rate by strain SS04 compared to SS04 without pVWEx1.Table 4Parameters for the whole-cell biotransformation of MAA to MHB with glucose as donor of reducing equivalents using the indicated *E. coli* strainsStrain/PlasmidMHB production rateGlucose uptake rateYield(mmol h^−1−^g~cdw~^−1^)(mmol h^−1^ g~cdw~^−1^)(mol~MHB~ mol~Glucose~^−1^)SS01/pVWEx18.5 ± 0.13.0 ± 0.12.9 ± 0.2SS01/pVWEx1-*glf-glk*8.6 ± 0.34.4 ± 0.21.9 ± 0.1SS02/pVWEx18.6 ± 0.32.3 ± 0.13.7 ± 0.2SS02/pVWEx1-*glf-glk*9.9 ± 0.43.0 ± 0.33.3 ± 0.3SS03/pVWEx18.6 ± 0.21.7 ± 0.24.7 ± 0.3SS03/pVWEx1-*glf-glk*10.3 ± 0.12.4 ± 0.34.4 ± 0.2SS04/pVWEx15.6 ± 0.31.0 ± 0.25.5 ± 0.3SS04/pVWEx1-*glf-glk*5.4 ± 0.41.4 ± 0.13.8 ± 0.4The detailed conditions are described in "Materials and methods." Mean values and standard deviations from at least three independent experiments are shown

Discussion {#Sec12}
==========

To improve reductive biotransformation we engineered the metabolic network of *E. coli*. Optimization of the yield was achieved by deleting phosphofructokinase genes resulting in a partial cyclization of the PPP. An increase of the glucose uptake rate by overexpression of the glucose facilitator gene *glf*, and the glucokinase gene *glk* from *Zymomonas mobilis* resulted in a higher specific biotransformation rate in the strains SS02 (*pgi* deletion) and SS03 (*pfkA* deletion).

Partial cyclization of the PPP in strain SS03 was confirmed by ^13^C metabolic flux analysis of cells grown in glucose minimal medium, which revealed a negative net flux from glucose 6-phosphate to fructose 6-phosphate catalyzed by phosphoglucose isomerase. Under resting cell conditions, this partial cyclization resulted in a significant increase of the whole-cell biotransformation yield. A yield of 4.7 mol~MHB~ mol~Glucose~^−1^ was attained with strain SS03, which contained residual phosphofructokinase activity originating from *pfkB*. Although not shown by ^13^C flux analysis, cyclic flux through the PPP should be even more intense in strain SS04 (*pfkApfkB* deletion) because the yield of strain SS04 with 5.5 mol~MHB~ mol~Glucose~^−1^ almost reached the theoretical maximum yield of 6 mol~NADPH~ mol~Glucose~^−1^ (Kruger and von Schaewen [@CR16]). Strain SS02 displayed a somewhat higher yield (3.7 mol~MHB~ mol~Glucose~^−1^) than theoretically expected for reasons discussed recently (Siedler et al. [@CR29]).

The Δ*pgi* and Δ*pfkA* mutant strains showed strongly reduced glucose uptake rates, in agreement with previous studies (Sauer et al. [@CR24]; Nanchen et al. [@CR18]). Several reasons for the lower glucose uptake rate have already been discussed in literature. The Δ*pgi* mutant has a high glucose 6-phosphate pool, which was reported to destabilize the *ptsG* mRNA and therefore decreases the glucose uptake capacity of the cell (Morita et al. [@CR17]). For the Δ*pfkA* mutant, a second assumption was reported by Roehl and Vinopal ([@CR22]) according to which the reduced PEP concentration in this mutant decreases the glucose uptake rate because PEP is essential for glucose uptake by the phosphotransferase system. This assumption is consistent with the carbon fluxes through the pyruvate kinase reaction determined here, which were lower in the Δ*pgi* mutant and nearly absent in the Δ*pfkA* mutant (Fig. [2](#Fig2){ref-type="fig"}).

In the SS01 strain, an increased glucose uptake rate did not result in higher rate of MAA reduction to MHB, indicating that another factor was limiting the rate of biotransformation, presumably NADPH availability (see below). In strains SS02 and SS03, glucose uptake limited the specific biotransformation rate, as shown by the increased MHB production rate upon overexpression of *glf* and *glk*.

For whole-cell biotransformation several limitations are possible, such as, enzyme activity, substrate import and product export, product toxicity, and cofactor regeneration rate, but most of them can be excluded in the model system used here. The alcohol dehydrogenase showed in vitro activities of 17 to 28 U mg^−1^ in cell extracts (Siedler et al. [@CR29]), which is comparable to a rate of at least 418 mmol h^−1^ g~cdw~^−1^ in vivo assuming that 41% of the cell dry weight is made up of soluble proteins (Zamboni et al. [@CR37]; Wittmann et al. [@CR36]). This value is 40 times higher than the observed specific biotransformation rate and consequently, ADH activity is not limiting. Substrate and product transport can also be ruled out as limiting factors, because biotransformation rates of 33 mmol~MHB~ h^−1^ g~cdw~^−1^ were previously achieved using a substrate coupled biotransformation strategy with ADH catalyzing both, the reduction of MAA and the regeneration of NADPH by oxidation of 2-propanol (Schroer et al. [@CR26]). With a formate dehydrogenase-coupled NADPH regeneration system, a value of 12 mmol~MHB~ h^−1^ g~cdw~^−1^ has been reported (Ernst et al. [@CR8]). For the conversion of MAA to MHB, it was shown that there is no substrate and product inhibition, and neither substrate nor product are toxic to the cells under the chosen conditions (Tan [@CR30]). Taken together, the biotransformation system used in this work is applicable for the detection of cofactor regeneration capabilities because this seems to be the limiting step.

Calculation of the NADH regeneration rate and transhydrogenase activity from ^13^C flux analysis in growing cells revealed differences in the analyzed strains (Fig. [2](#Fig2){ref-type="fig"}). The relative fluxes through the soluble transhydrogenase UdhA converting NADPH to NADH were 2.5 and 4.1 times higher in the Δ*pgi* mutant and the Δ*pfkA* mutant compared to the reference strain, respectively (Table [3](#Tab3){ref-type="table"}). The yield of the biotransformation increased 1.3-fold in the SS02 strain and 1.6-fold in the SS03 strain compared to the SS01 strain, which indicated that under resting cell conditions ADH was competitive to UdhA with respect to NADPH utilization. Hence, deletion of UdhA would probably result in an increased yield, as was already demonstrated with another biotransformation system (Chin and Cirino [@CR4]).

Having increased product yield and production rate by different strategies, future studies aim to combine these and additional strategies for further optimization of reductive whole-cell redox biocatalysis.
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